Diagnosis and epidemiology of human herpesvirus 8 infection

Seminars in Hematology

Volumn 40, Issue 2, 2003, Pages 133-142

  Martin, Jeffrey N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; VIRUS ANTIBODY;

ACCURACY; AFRICA; ANTIBODY DETECTION; ASSAY; BLOOD TRANSFUSION; CHILDHOOD; DRUG USE; ENDEMIC DISEASE; EUROPE; HERPES VIRUS INFECTION; HOMOSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; INTRAVENOUS DRUG ABUSE; KAPOSI SARCOMA; MIDDLE EAST; NONHUMAN; NUCLEIC ACID ANALYSIS; ORGAN TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SALIVA; SEROCONVERSION; SEROLOGY; SEXUAL TRANSMISSION; SOUTHERN EUROPE; UNITED STATES; VIRUS TRANSMISSION;

EID: 0037392322     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(03)70005-5     Document Type: Review

References (84)

1. Andreoni M, El-Sawaf G, Rezza G, et al: High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: Evidence of nonsexual transmission. J Natl Cancer Inst 91:465-469, 1999
2. Andreoni M, Goletti D, Pezzotti P, et al: Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect 43:195-199, 2001
3. Angeloni A, Heston L, Uccini S, et al: High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis 177:1715-1718, 1998
4. Archibald CP, Schechter MT, Craib KJ, et al: Risk factors for Kaposi's sarcoma in the Vancouver Lymphadenopathy-AIDS Study. J Acquir Immune Defic Syndr 3:S18-23, 1990 (suppl 1)
5. Beral V, Bull D, Darby S, et al: Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet 339:632-635, 1992
6. Beral V, Peterman TA, Berkelman RL, et al: Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection? Lancet 335:123-128, 1990
7. Bestetti G, Renon G, Mauclere P, et al: High seroprevalence of human herpesvirus-8 in pregnant women and prostitutes from Cameroon. AIDS 12:541-543, 1998 (letter)
8. Blackbourn DJ, Ambroziak J, Lennette E, et al: Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 349:609-611, 1997
9. Bourboulia D, Whitby D, Boshoff C, et al: Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection. JAMA 280:31-32, 1998 (letter)
10. Cannon MJ, Dollard SC, Smith DK, et al: Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study Group. N Engl J Med 344:637-643, 2001
11. Casper C, Wald A, Pauk J, et al: Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men. J Infect Dis 185:990-993, 2002
12. Cesarman E, Chang Y, Moore PS, et al: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas N Engl J Med 332:1186-1191, 1995
13. Chandran B, Smith MS, Koelle DM, et al: Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. Virology 243:208-217, 1998
14. Chang Y, Cesarman E, Pessin MS, et al: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869, 1994
15. Chatlynne LG, Lapps W, Handy M, et al: Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 92:53-58, 1998
16. Chokunonga E, Levy LM, Bassett MT, et al: Cancer incidence in the African population of Harare, Zimbabwe: Second results from the cancer registry 1993-1995. Int J Cancer 85:54-59, 2000
17. Corchero JL, Mar EC, Spira TJ, et al: Comparison of serologic assays for detection of antibodies against human herpesvirus 8. Clin Diagn Lab Immunol 8:913-921, 2001
18. Davidovici B, Karakis I, Bourboulia D, et al: Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J Natl Cancer Inst 93:194-202, 2001
19. Davis DA, Humphrey RW, Newcomb FM, et al: Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide. J Infect Dis 175:1071-1079, 1997
20. de Sanjose S, Marshall V, Sola J, et al: Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain. Int J Cancer 98:155-158, 2002
21. Diamond C, Huang ML, Kedes DH, et al: Absence of detectable human herpesvirus 8 in the semen of human immunodeficiency virus-infected men without Kaposi's sarcoma. J Infect Dis 176:775-777, 1997
22. Diamond C, Thiede H, Perdue T, et al: Seroepidemiology of human herpesvirus 8 among young men who have sex with men. The Seattle Young Men's Survey Team. Sex Transm Dis 28:176-183, 2001
23. Diociaiuti A, Nanni G, Cattani P, et al: HHV8 in renal transplant recipients. Transplant Int 13:S410-412, 2000 (suppl 1)
24. Drew WL, Conant MA, Miner RC, et al: Cytomegalovirus and Kaposi's sarcoma in young homosexual men. Lancet 2:125-127, 1982
25. Dukers NH, Renwick N, Prins M, et al: Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol 151:213-224, 2000
26. Dukers NHTM, Renwick N, Prins M, et al: Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol 151:213-224, 2000
27. Elford J, Tindall B, Sharkey T: Kaposi's sarcoma and insertive rimming. Lancet 339:938, 1992 (letter)
28. Engels EA, Whitby D, Goebel PB, et al: Identifying human herpesvirus 8 infection: Performance characteristics of serologic assays. J Acquir Immune Defic Syndr 23:346-354, 2000
29. Gao SJ, Kingsley L, Hoover DR, et al: Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 335:233-241, 1996
30. Gao SJ, Kingsley L, Li M, et al: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2:925-928, 1996
31. Gessain A, Mauclere P, van Beveren M, et al: Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer 81:189-192, 1999
32. Greenblatt RM, Jacobson LP, Levine AM, et al: Human herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women. J Infect Dis 183:1130-1134, 2001
33. Grulich AE, Kaldor JM, Hendry O, et al: Risk of Kaposi's sarcoma and oroanal sexual contact. Am J Epidemiol 145:673-679, 1997
34. Grulich AE, Olsen SJ, Luo K, et al: Kaposi's sarcoma-associated herpesvirus: A sexually transmissible infection? J Acquir Immune Defic Syndr Hum Retrovirol 20:387-393, 1999
35. Gutierrez-Ortega P, Hierro-Orozco S, Sanchez-Cisneros R, et al: Kaposi's sarcoma in a 6-day-old infant with human immunodeficiency virus. Arch Dermatol 125:432-433, 1989
36. Huang YQ, Li JJ, Rush MG, et al: HPV-16-related DNA sequences in Kaposi's sarcoma Lancet 339:515-518, 1992
37. IARC Working Group: Kaposi's sarcoma herpesvirus/human herpesvirus 8. IARC Monogr Eval Carcinog Risks Hum 70:375-492, 1997
38. Inoue N, Mar EC, Dollard SC, et al: New immunofluorescence assays for detection of human herpesvirus 8-specific antibodies. Clin Diagn Lab Immunol 7:427-435, 2000
39. Jacobson LP, Munoz A, Fox R, et al: Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with the human immunodeficiency virus type 1. The Multicenter AIDS Cohort Study Group. J Acquir Immune Defic Syndr 3:S24-31, 1990 (suppl 1)
40. Jacobson LP, Springer G, Jenkins FJ, et al: HHV-8 infection: Incidence and risk factors in the Multicenter AIDS Cohort Study (MACS). Third International Workshop on Kaposi Sarcoma-Associated Herpesviruses and Related Agents, Amherst, MA, July 6-10, 2000
41. Kedes DH, Ganem D, Ameli N, et al: The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. JAMA 277:478-481, 1997
42. Kedes DH, Lagunoff M, Renne R, et al: Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest 100:2606-2610, 1997
43. Kedes DH, Operskalski E, Busch M, et al: The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2:918-924, 1996
44. Koelle DM, Huang ML, Chandran B, et al: Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: Clinical and immunologic correlates. J Infect Dis 176:94-102, 1997
45. Lam LL, Pau CP, Dollard SC, et al: Highly sensitive assay for human herpesvirus 8 antibodies that uses a multiple antigenic peptide derived from open reading frame K8.1. J Clin Microbiol 40:325-329, 2002
46. Lifson AR, Darrow WW, Hessol NA, et al: Kaposi's sarcoma in a cohort of homosexual and bisexual men. Epidemiology and analysis for cofactors Am J Epidemiol 131:221-231, 1990
47. Luppi M, Barozzi P, Santagostino G, et al: Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood 96:3279-3281, 2000
48. Mantina H, Kankasa C, Klaskala W, et al: Vertical transmission of Kaposi's sarcoma-associated herpesvirus. Int J Cancer 94:749-752, 2001
49. Martin JN, Amad Z, Cossen C, et al: Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies. J Clin Microbiol 38:696-701, 2000
50. Martin JN, Ganem DE, Osmond DH, et al: Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 338:948-954, 1998
51. Martin JN, Osmond DH: Kaposi's sarcoma-associated herpesvirus and sexual transmission of cancer risk. Curr Opin Oncol 11:508-515, 1999
52. Martin JN, Osmond DH: Invited commentary: Determining specific sexual practices associated with human herpesvirus 8 transmission. Am J Epidemiol 151:225-229, 2000
53. Mayama S, Cuevas LE, Sheldon J, et al: Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 77:817-820, 1998
54. Melbye M, Cook PM, Hjalgrim H, et al: Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer 77:543-548, 1998
55. Miller G, Rigsby MO, Heston L, et al: Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 334:1292-1297, 1996
56. O'Brien T, Kedes D, Ganem D, et al: Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: Rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis 180:1010-1017, 1999
57. Olsen SJ, Chang Y, Moore PS, et al: Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 12:1921-1925, 1998
58. Osmond DH, Buchbinder S, Cheng A, et al: Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. JAMA 287:221-225, 2002
59. Page-Bodkin K, Tappero J, Samuel M, et al: Kaposi's sarcoma and faecal-oral exposure. Lancet 339:1490, 1992 (letter)
60. Pau CP, Lam LL, Spira TJ, et al: Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol 36:1574-1577, 1998
61. Pauk J, Huang ML, Brodie SJ, et al: Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 343:1369-1377, 2000
62. Plancoulaine S, Abel L, van Beveren M, et al: Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 356:1062-1065, 2000
63. Quinlivan EB, Wang RX, Stewart PW, et al: Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS. Swiss HIV Cohort Study. J Med Virol 64:157-166, 2001
64. Rabkin CS, Schulz TF, Whitby D, et al: Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis 178:304-309, 1998
65. Rainbow L, Platt GM, Simpson GR, et al: The 222- to 234- kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71:5915-5921, 1997
66. Ransohoff DF, Feinstein AR: Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 299:926-930, 1978
67. Regamey N, Tamm M, Wernli M, et al: Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 339:1358-1363, 1998
68. Renwick N, Dukers NH, Weverling GJ, et al: Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996. J Infect Dis 185:1808-1812, 2002
69. Renwick N, Halaby T, Weverling GJ, et al: Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 12:2481-2488, 1998
70. Rezza G, Lennette ET, Giuliani M, et al: Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer 77:361-365, 1998
71. Rezza G, Tchangmena OB, Andreoni M, et al: Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sex Transm Dis 27:159-164, 2000
72. Simpson GR, Schulz TF, Whitby D, et al: Prevalence of Kaposi's sarcoma associated herpesvirus infection by antibodies to recombinant capsid protein and latent antigen. Lancet 348:1133-1138, 1996
73. Sitas F, Carrara H, Beral V, et al: Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med 340:1863-1871, 1999
74. Smith NA, Sabin CA, Gopal R, et al: Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis 180:600-606, 1999
75. Soulier J, Grollet L, Oksenhendler E, et al: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280, 1995
76. Spira TJ, Lam L, Dollard SC, et al: Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol 38:2174-2180, 2000
77. Tedeschi R, Caggiari L, Silins I, et al: Seropositivity to human herpesvirus 8 in relation to sexual history and risk of sexually transmitted infections among women. Int J Cancer 87:232-235, 2000
78. Tedeschi R, De Paoli P, Schulz TF, et al: Human serum antibodies to a major defined epitope of human herpesvirus 8 small viral capsid antigen. J Infect Dis 179:1016-1020, 1999
79. US Public Health Service and Infectious Diseases Society of America: Guidelines for preventing opportunistic infections among HIV-infected persons. MMWR Morb Mortal Wkly Rep 51:1-46, 2002
80. Vitale F, Viviano E, Perna AM, et al: Serological and virological evidence of non-sexual transmission of human herpesvirus type 8 (HHV8). Epidemiol Infect 125:671-675, 2000
81. Wang RY, Shih JW, Weiss SH, et al: Mycoplasma penetrans infection in male homosexuals with AIDS: High seroprevalence and association with Kaposi's sarcoma. Clin Infect Dis 17:724-729, 1993
82. Wawer MJ, Eng SM, Serwadda D, et al: Prevalence of Kaposi sarcoma-associated herpesvirus compared with selected sexually transmitted diseases in adolescents and young adults in rural Rakai District, Uganda. Sex Transm Dis 28:77-81, 2001
83. Whitby D, Howard MR, Tenant-Flowers M, et al: Detection of Kaposi sarcoma associated herpesvirus in peripheral blood HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346:799-802, 1995
84. Whitby D, Luppi M, Barozzi P, et al: Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 90:395-397, 1998